300 related articles for article (PubMed ID: 27438806)
21. White matter NAA/Cho and Cho/Cr ratios at MR spectroscopy are predictive of motor outcome in preterm infants.
Kendall GS; Melbourne A; Johnson S; Price D; Bainbridge A; Gunny R; Huertas-Ceballos A; Cady EB; Ourselin S; Marlow N; Robertson NJ
Radiology; 2014 Apr; 271(1):230-8. PubMed ID: 24475798
[TBL] [Abstract][Full Text] [Related]
22. Proton magnetic resonance spectroscopy in immunocompetent patients with primary central nervous system lymphoma.
Raizer JJ; Koutcher JA; Abrey LE; Panageas KS; DeAngelis LM; Lis E; Xu S; Zakian KL
J Neurooncol; 2005 Jan; 71(2):173-80. PubMed ID: 15690135
[TBL] [Abstract][Full Text] [Related]
23. Monovoxel 1H magnetic resonance spectroscopy in the progression of gliomas.
Alimenti A; Delavelle J; Lazeyras F; Yilmaz H; Dietrich PY; de Tribolet N; Lövblad KO
Eur Neurol; 2007; 58(4):198-209. PubMed ID: 17823533
[TBL] [Abstract][Full Text] [Related]
24. Metabolic abnormality of pontine tegmentum in patients with REM sleep behavior disorder analyzed using magnetic resonance spectroscopy.
Zhang L; Xu Y; Zhuang J; Peng H; Wu H; Zhao Z; He B; Zhao Z
Clin Neurol Neurosurg; 2016 Sep; 148():137-41. PubMed ID: 27448046
[TBL] [Abstract][Full Text] [Related]
25. Multisection 1H magnetic resonance spectroscopic imaging assessment of glioma response to chemotherapy.
Balmaceda C; Critchell D; Mao X; Cheung K; Pannullo S; DeLaPaz RL; Shungu DC
J Neurooncol; 2006 Jan; 76(2):185-91. PubMed ID: 16151595
[TBL] [Abstract][Full Text] [Related]
26. Developing a clinical decision model: MR spectroscopy to differentiate between recurrent tumor and radiation change in patients with new contrast-enhancing lesions.
Smith EA; Carlos RC; Junck LR; Tsien CI; Elias A; Sundgren PC
AJR Am J Roentgenol; 2009 Feb; 192(2):W45-52. PubMed ID: 19155380
[TBL] [Abstract][Full Text] [Related]
27. In vivo research in astrocytoma cell proliferation with 1H-magnetic resonance spectroscopy: correlation with histopathology and immunohistochemistry.
Chen J; Huang SL; Li T; Chen XL
Neuroradiology; 2006 May; 48(5):312-8. PubMed ID: 16552583
[TBL] [Abstract][Full Text] [Related]
28. Multimodal Magnetic Resonance Imaging of Treatment-Induced Changes to Diffuse Infiltrating Pontine Gliomas in Children and Correlation to Patient Progression-Free Survival.
Calmon R; Puget S; Varlet P; Beccaria K; Blauwblomme T; Grevent D; Sainte-Rose C; Castel D; Dufour C; Dhermain F; Bolle S; Saitovitch A; Zilbovicius M; Brunelle F; Grill J; Boddaert N
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):476-485. PubMed ID: 28871999
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of
Tinkle CL; Duncan EC; Doubrovin M; Han Y; Li Y; Kim H; Broniscer A; Snyder SE; Merchant TE; Shulkin BL
J Nucl Med; 2019 Mar; 60(3):312-319. PubMed ID: 30072503
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of early cerebral metabolic, perfusion and microstructural changes in HCV-positive patients: a pilot study.
Bladowska J; Zimny A; Knysz B; Małyszczak K; Kołtowska A; Szewczyk P; Gąsiorowski J; Furdal M; Sąsiadek MJ
J Hepatol; 2013 Oct; 59(4):651-7. PubMed ID: 23680314
[TBL] [Abstract][Full Text] [Related]
31. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the late effects of CNS prophylactic treatment in childhood acute lymphoblastic leukemia (ALL) using magnetic resonance spectroscopy.
Ficek K; Blamek S; Syguła D; Miszczyk L; Sońta-Jakimczyk D; Tarnawski R
Acta Neurochir Suppl; 2010; 106():195-7. PubMed ID: 19812948
[TBL] [Abstract][Full Text] [Related]
33. [Brain metabolic disorders after chemotherapy in the study by magnetic resonance spectroscopy].
Ciszkowska-Łysoń B; Królicki L; Teska A; Janowicz-Zebrowska A; Krzakowski M; Tacikowska M
Neurol Neurochir Pol; 2003; 37(4):783-98. PubMed ID: 14746239
[TBL] [Abstract][Full Text] [Related]
34. Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder.
Iranzo A; Santamaria J; Pujol J; Moreno A; Deus J; Tolosa E
Sleep; 2002 Dec; 25(8):867-70. PubMed ID: 12489892
[TBL] [Abstract][Full Text] [Related]
35. Dynamic 1H-MRS assessment of brain tumors: a novel approach for differential diagnosis of glioma.
Tong T; Yang Z; Chen JW; Zhu J; Yao Z
Oncotarget; 2015 Oct; 6(31):32257-65. PubMed ID: 26337080
[TBL] [Abstract][Full Text] [Related]
36. Global brain metabolic quantification with whole-head proton MRS at 3 T.
Kirov II; Wu WE; Soher BJ; Davitz MS; Huang JH; Babb JS; Lazar M; Fatterpekar G; Gonen O
NMR Biomed; 2017 Oct; 30(10):. PubMed ID: 28678429
[TBL] [Abstract][Full Text] [Related]
37. Metabolic changes in normal-appearing white matter in patients with neuromyelitis optica and multiple sclerosis: a comparative magnetic resonance spectroscopy study.
Duan Y; Liu Z; Liu Y; Huang J; Ren Z; Sun Z; Chen H; Dong H; Ye J; Li K
Acta Radiol; 2017 Sep; 58(9):1132-1137. PubMed ID: 28173728
[TBL] [Abstract][Full Text] [Related]
38. Proton magnetic resonance spectroscopy of brain-stem lesions.
Smith JK; Londono A; Castillo M; Kwock L
Neuroradiology; 2002 Oct; 44(10):825-9. PubMed ID: 12389131
[TBL] [Abstract][Full Text] [Related]
39. Assessment of mitochondrial impairment in traumatic brain injury using high-resolution proton magnetic resonance spectroscopy.
Signoretti S; Marmarou A; Aygok GA; Fatouros PP; Portella G; Bullock RM
J Neurosurg; 2008 Jan; 108(1):42-52. PubMed ID: 18173309
[TBL] [Abstract][Full Text] [Related]
40. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O
Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]